Clinical Trials Sponsored by ActoGeniX N.V.

Total 1480 results

Galapagos NV

Completed

This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects

Healthy | Elderly

Belgium
FLUIDDA nv

Completed

Transplant Optimization Using Functional Imaging (TROFI) (TROFI_BE)

Bronchiolitis Obliterans | Lung Transplant Rejection

Belgium
Novosanis NV

Completed

Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID (POC_VAX-ID)

Hepatitis B

Belgium
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG1972

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG2222

Healthy

Belgium
FLUIDDA nv

Withdrawn

The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers

Asthma

Belgium
Galapagos NV

Completed

A Phase I, Open Interaction Study Between GLPG1837 and Midazolam in Healthy Male Subjects

Healthy

Belgium
Novosanis NV

Completed

Echographic Measurement of Skin Thickness

Skin Thickness

Belgium
FLUIDDA nv

Completed

Research to Evaluate a Possible Relation Between Values Obtained After Processing CT Images, Lung Function Tests and the Experience of the Patient During an Exacerbation in COPD Patients.

Pulmonary Disease, Chronic Obstructive

Netherlands, Belgium, Italy
Galapagos NV

Completed

Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG1205

Healthy

Belgium
Galapagos NV

Completed

Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Hungary, Moldova, Republic of, Russian Federation, Ukraine
Galapagos NV

Completed

Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects

Healthy

United Kingdom
Galapagos NV

Completed

Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects

Healthy

Belgium
FLUIDDA nv

Completed

Modelling of the Upper Airway in Children With Controlled Asthma

Controlled Asthma

Belgium
Galapagos NV

Completed

Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Moldova, Republic of
Galapagos NV

Completed

First-in-Human Single Ascending and Multiple Dose of GLPG0259

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single Ascending and Multiple Dose of GLPG0778

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single Ascending and Multiple Dose of GLPG0634

Healthy

Belgium
Galapagos NV

Completed

Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects

Healthy

Belgium
Galapagos NV

Completed

First-in-Human Single Ascending and Multiple Dose of GLPG0555

Healthy

Belgium
uniQure France SAS

Recruiting

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

Mesial Temporal Lobe Epilepsy

United States
Erasmus Medical Center
ISA Pharmaceuticals B.V.

Recruiting

Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104 (HEB-PEP)

Chronic Hepatitis b

Netherlands
Alloksys Life Sciences B.V.
Aix Scientifics

Recruiting

Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase (APPIRED-III)

Systemic Inflammation | Cardiopulmonary-bypass

Australia, Austria, Belgium, Germany, Italy, Malaysia, Portugal, Netherlands, Russian Federation, Singapore, Spain
University of Reading
Winclove Probiotics B.V.

Completed

Acute and Chronic Effects of Ecologic Barrier© on Mood and Cognition (ProCog)

Cognitive Change | Mood

United Kingdom
Janssen Vaccines & Prevention B.V.
Bavarian Nordic

Terminated

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Human Papillomavirus Infections

United States, Belgium
Maastricht University Medical Center
BioActor B.V.

Completed

The Effect of Aronia Melanocarpa Extract on Cognitive Function

Cognitive Function

Netherlands
Maastricht University Medical Center
BioActor B.V.

Completed

The Effect of Berry Extract Administration on Cognitive Health

Cognitive Impairment | Overweight and Obesity

Netherlands
Schön Klinik Berchtesgadener Land
Lungenfibrose e.V.

Terminated

Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation

Idiopathic Pulmonary Fibrosis and COPD

Germany
Voronezh N.N. Burdenko State Medical Academy

Completed

Hardware Wound Healing In Surgical Treatment Of Sacrococcygeal Pilonidal Sinus Disease (HWHPSD)

Sacrococcygeal Pilonidal Sinus Disease

Russian Federation
Voronezh N.N. Burdenko State Medical Academy

Completed

New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers

Ulcer Hemorrhage

Russian Federation
Erasmus Medical Center
Cardialysis B.V.; Feops

Completed

Added Value of Patient-specific Computer Simulation in Transcatheter Aortic Valve Implantation (TAVI) (TAVIguide)

Aortic Valve Stenosis

Belgium, Denmark, Germany, Italy, Netherlands
UniQure Biopharma B.V.
Chiesi Farmaceutici S.p.A.

Withdrawn

Alipogene Tiparvovec for the Treatment of LPLD Patients

LPL Deficiency

Canada, United States
Maastricht University Medical Center
FABPulous B.V.

Completed

Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome (RAPIDA)

Acute Coronary Syndrome | Thoracic Diseases | Angina Pectoris, Stable | Angina Pectoris, Unstable

Belgium, Netherlands
Alloksys Life Sciences B.V.
Aix Scientifics

Completed

Efficacy and Safety of Bovine Intestinal Alkaline Phosphatase (bIAP) During Heart Surgery (APPIRED-II)

Inflammation

Netherlands
Institut für Pharmakoökonomie und Arzneimittellogistik...

Completed

Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA

Atrial Fibrillation | Stroke Prophylaxis
Bayer
Corporación Bonima S.A. de C.V.

Completed

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules

Anti-Infective Agents

Mexico
University Hospital, Brest
MCM Vaccines B.V.

Completed

Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France. (IVANHOE)

Rotavirus Gastroenteritis

France
University of North Carolina
Janssen Pharmaceutica N.V., Belgium

Completed

Sleep Disorders and Gastroesophageal Reflux Disease (GERD)

Insomnia | GERD

United States
Bassett Healthcare
Genentech, Inc.; Viroclinics Biosciences B.V.

Recruiting

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1) (COMBO 1)

Influenza

United States
University Medical Center Groningen
Janssen-Cilag B.V.

Completed

A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa (HiTS)

Hidradenitis Suppurativa

Netherlands
Pharming Technologies B.V.
US Hereditary Angioedema Association

Completed

Patient Registry to Evaluate the Real-world Safety of Ruconest®

Hereditary Angioedema

United States
Radboud University Medical Center
Goodlife Fertility B.V.

Active, not recruiting

The Impact of a Nutritional Supplement (Impryl®) on Male Fertility (SUMMER)

Male Subfertility

Netherlands
Kuros Biosurgery AG
Avania; Kuros BioSciences B.V.

Active, not recruiting

KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion (STRUCTURE)

Degenerative Disc Disease | Spinal Fusion

United States
Medical University of Warsaw
Winclove Probiotics B.V.

Completed

The Effect of a Multispecies Probiotic on Reducing the Incidence of Antibiotic-associated Diarrhoea in Children.

Antibiotic-associated Diarrhea

Poland, Netherlands
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder

Overactive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor Overactivity

Belgium, Denmark, Norway, Poland, Serbia
Astellas Pharma Europe B.V.

Completed

A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects

Healthy Volunteers

United States
University Hospital, Gentofte, Copenhagen
MCM Vaccines B.V.

Completed

The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects (Px-Lixi)

Diabetes After Total Pancreatectomy
Astellas Pharma Europe B.V.

Completed

A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis (SERENITY)

Interstitial Cystitis | Bladder Pain Syndrome

Spain, Russian Federation, Belgium, Czechia, Germany, Hungary, Latvia, Netherlands, Poland, United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Healthy Subjects | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD) | Pharmacokinetics of ASP8232 | Pharmacodynamics of ASP8232

Bulgaria, Moldova, Republic of, Romania

3

Subscribe